Trial Profile

A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 26 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin (Primary) ; Insulin icodec
Indications Type 2 diabetes mellitus
Focus Registrational; Therapeutic Use
Acronyms SUPER-8
Sponsors Gan&Lee Pharmaceuticals

Most Recent Events

12 Jun 2026 According to a Gan & Lee Pharmaceuticals media release, results from this study scheduled to be presented at future scientific conferences and published in international academic journals.
25 Nov 2025 Status changed from not yet recruiting to recruiting.
18 Sep 2025 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com